When an unexpected health issue arises, it is not just the individual who is affected, but their family and their community as well. As surgeons, our mission is to develop the best possible way to serve our patients, and to give hope to their families and communities by helping them understand and participate in the process. Many of our colleagues have shared with us their vision for how the ability to target and illuminate nerves might one day help their patients - and their stories both inspire us and help us to evolve this technology.
Dr. Jeremy Richmon is a pioneer in minimally-invasive robotic techniques in the head and neck. He was the first surgeon to perform transoral robotic surgery at Johns Hopkins in 2009, and was also the first surgeon in the United States to perform transoral robotic thyroidectomy in 2016, a technique he helped develop. He joined the faculty at Johns Hopkins in 2008 and served as the Director of the Head and Neck Surgery Robotic Program until joining the Mass. Eye and Ear Head and Neck Division as a Clinical Associate and the Harvard Medical School faculty in 2016.
Dr. Allan D. Kirk is the Department of Surgery Chairman and David C. Sabiston, Jr. Professor of Surgery at Duke University, and Surgeon-in-Chief of the Duke University Health System. He is a transplant surgeon specializing in kidney transplants with a focus on manipulating patient immune systems to accept their transplant organ while rejecting pathogens. He also works with the military to develop better ways to improve the lives of people who have been critically injured. He assembled the surgical team led by Dr. Linda Cendales that performed North Carolina's first hand transplant in 2016.
Dr. Eben Rosenthal serves as the Ann and John Doerr Medical Director of the Stanford Cancer Center, a position he has held since July 2015. He oversees the clinical delivery of cancer care across Stanford Medicine and regional cancer networks. He is clinically active in microvascular reconstruction of complex head and neck defects. As a surgeon-scientist, Dr. Rosenthal has conducted multiple early phase clinical trials for diagnostic and therapeutic agents for the treatment of solid tumors. He leads a multidisciplinary team of clinical and basic scientists that have successfully performed first in human clinical trials using fluorescently labeled antibodies as a cancer specific contrast agent for use in the operating room.
Dr. Justin M. Brown is an Associate Professor in the Neurosurgery Division at UCSD, Director of the Neurosurgery Peripheral Nerve Program and Co-Director of the Center for Neurophysiology and Restorative Neurology. His clinical interests include brachial plexus injury and other peripheral nerve trauma of the upper and lower extremities, nerve transfers, nerve sheath tumors, thoracic outlet syndrome, and nerve compression syndromes, including carpal and cubital tunnel syndromes.
"I didn't think I would ever be able to smile again. Thank you for all that you and your staff have done to make this surgery a success."
"John's surgery was one of the hardest things we have ever faced together. Thank you for taking such great care of him. We are looking forward to beginning his recovery."
"Our lives were turned upside down 6 months ago. If someone had told us then what our father is able to do today, we would not have believed it."